Collecting liver samples to build models for liver cancer and liver disease research
Collects blood and biopsy samples from adults with liver disease or liver cancer for research.
Plain-language title generated from the registry record
Registry title: "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Key facts
- Where
- Strasbourg, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a long-term liver disease or a liver nodule, who already have a biopsy, liver surgery or liver cancer treatment planned as part of their care. Samples are collected to build lab models of liver disease.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Chronic liver disease (viral or not), or at least one liver nodule with a biopsy planned, or hepatobiliary surgery planned, or local treatment for HCC (liver cancer) indicated
Main reasons for not taking part
- Minors
- People under legal protection or unable to give consent
- People in a situation of social fragility
- Pregnant or breastfeeding women
- People who do not sign the informed consent
Read by machine on 12 November 2026.
Where in France
- PU-PH, Directeur de l'UMR_S1110 Unité Inserm d'affiliation : UMR_S1110Strasbourg, FranceContact: Thomas BAUMERT, DrTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Institut National de la Santé Et de la Recherche Médicale, France
- Trial code
- NCT04690972
- Record updated
- 22 October 2026
- Original description
Development of preclinical translational models for chronic liver tumors and diseases study, such as spheroids cultured in autologous medium and murine xenograft models to test the efficacy of new therapeutic strategies.Read full original descriptionShow less
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Development of preclinical translational models for chronic liver tumors and diseases study, such as spheroids cultured in autologous medium and murine xenograft models to test the efficacy of new therapeutic strategies.
Inclusion: Patients; diagnosed with chronic liver disease (viral or not); diagnosed with at least one liver nodule for which a biopsy is planned as part of the care; for hepatobiliary surgery planned as part of care; for locoregional treatment for HCC is indicated; Patients able to receive and understand information relating to the study and give their written informed consent; Patients affiliated to the French social security system.
Exclusion: Minor patients; Patients under legal protection,; Patients subject to legal protection or unable to express their consent,; Patients in a situation of social fragility,; Pregnant or breastfeeding woman,; No signing of informed consent.